FDA Inspection 1107432 — Rommelag CDMO GmbH
The FDA completed an inspection of Rommelag CDMO GmbH on September 17, 2019 in Sulzbach-Laufen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sulzbach-Laufen (Germany)